Impact of schizophrenia and chronic antipsychotic treatment on [ 123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo

Biological Psychiatry

Volumn 58, Issue 1, 2005, Pages 41-46

  Bressan, Rodrigo A ^a   Erlandsson, Kjell ^b   Stone, James M ^a   Mulligan, Rachel S ^b   Krystal, John H ^c,d   Ell, Peter J ^b   Pilowsky, Lyn S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Antipsychotics; Clozapine; NMDA; Schizophrenia; SPECT; SPET

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; CNS 1261; N (1 NAPHTHYL) N (3 IODOPHENYL) N METHYLGUANIDINE I 123; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; QUINIDINE DERIVATIVE; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RADIOASSAY; RECEPTOR BINDING; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUANIDINES; HUMANS; IODINE RADIOISOTOPES; MALE; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 21344433446     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.03.016     Document Type: Article

References (58)

1. D. Addington, J. Addington, E. Maticka-Tyndale Assessing depression in schizophrenia The Calgary Depression Scale Br J Psychiatry 163 1993 39 44
2. Alcohol Drug Abuse and Mental Health Administration Abnormal involuntary movement scale (AIMS) 1974 Department of Health, Education and Welfare Washington, DC
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th edition 1994 Author Washington, DC
4. M.I. Aparicio-Legarza, B. Davis, P.H. Hutson, G.P. Reynolds Increased density of glutamate/N-methyl-D-aspartate receptors in putamen from schizophrenic patients Neurosci Lett 241 1998 143 146
5. T.R. Barnes A rating scale for drug-induced akathisia Br J Psychiatry 154 1989 672 676
6. 123I]CNS 1261 Comparison with bolus studies Nucl Med Biol 31 2004 155 164
7. R.A. Bressan, L.S. Pilowsky Imaging the glutamatergic system in vivo-relevance to schizophrenia Eur J Nucl Med 27 2000 1723 1731
8. L.M. Brzustowicz, J. Simone, P. Mohseni, J.E. Hayter, K.A. Hodgkinson, E.W. Chow, A.S. Bassett Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22 Am J Hum Genet 74 2004 1057 1063 (Epub 2004 Apr 02)
9. M.S. Buchsbaum, S.G. Potkin, J.F. Marshall, S. Lottenberg, C. Teng, C.W. Heh Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia Neuropsychopharmacology 6 1992 155 163
10. L. Chen, C.R. Yang Interaction of dopamine D1 and NMDA receptors mediates acute clozapine potentiation of glutamate EPSPs in rat prefrontal cortex J Neurophysiol 87 2002 2324 2336
11. H.J. Chiu, Y.C. Wang, Y.J. Liou, I.C. Lai, J.Y. Chen Association analysis of the genetic variants of the N-methyl D-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese Neuropsychobiology 47 2003 178 181
12. R.M. Cohen, T.E. Nordahl, W.E. Semple, D. Pickar The brain metabolic patterns of clozapine- and fluphenazine-treated female patients with schizophrenia Evidence of a sex effect Neuropsychopharmacology 21 1999 632 640
13. J.T. Coyle, G. Tsai, D. Goff Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia Ann N Y Acad Sci 1003 2003 318 327
14. E. Di Maria, R. Gulli, S. Begni, A. De Luca, S. Bignotti, A. Pasini Variations in the NMDA receptor subunit 2B gene (GRIN2B) and schizophrenia A case-control study Am J Med Genet 128B 2004 27 29
15. J. Endicott, R.L. Spitzer, J.L. Fleiss, J. Cohen The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance Arch Gen Psychiatry 33 1976 766 771
16. 123I]-CNS 1261-a novel SPET tracer for the NMDA receptor Nucl Med Biol 30 2003 441 454
17. L.W. Fitzgerald, A.Y. Deutch, G. Gasic, S.F. Heinemann, E.J. Nestler Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs J Neurosci 15 1995 2453 2461
18. P. Follesa, M.K. Ticku NMDA receptor upregulation molecular studies in cultured mouse cortical neurons after chronic antagonist exposure J Neurosci 16 1996 2172 2178
19. K.J. Friston, J. Ashburner, J.B. Poline, C.D. Frith, J.D. Heather, R.S.J. Frackowiak Spatial registration and normalisation of images Hum Brain Mapp 2 1995 165 189
20. X.M. Gao, K. Sakai, R.C. Roberts, R.R. Conley, B. Dean, C.A. Tamminga Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus effects of schizophrenia Am J Psychiatry 157 2000 1141 1149
21. 3H]MK801-binding sites in the rat brain A side-preference action in cortical areas Brain Res 762 1997 216 218
22. D.C. Goff, D.C. Henderson, A.E. Evins, E. Amico A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia Biol Psychiatry 45 1999 512 514
23. Guy W (1976): U.S. Department of Health and Human Services Publication ADM 76-338 Rockville, MD: Author. 217-222
24. E.H. Hamid, T.M. Hyde, S.M. Baca, M.F. Egan Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia Brain Res 796 1998 291 295
25. X.J. Hu, M.K. Ticku Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons Brain Res Mole Brain Res 30 1995 347 356
26. J.E. Huettner, B.P. Bean Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801 Selective binding to open channels Proc Natl Acad Sci U S A 85 1988 1307 1311
27. H.M. Ibrahim, A.J. Hogg Jr, D.J. Healy, V. Haroutunian, K.L. Davis, J.H. Meador-Woodruff Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia Am J Psychiatry 157 2000 1811 1823
28. V.I. Ilyin, E.R. Whittemore, J. Guastella, E. Weber, R.M. Woodward Subtype-selective inhibition of methyl-D-aspartate receptors by haloperidol Mol Pharmacol 50 1996 1541 1550
29. S.R. Kay, A. Fiszbein, L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
30. J.H. Krystal, D.C. D'Souza, D. Mathalon, E. Perry, A. Belger, R. Hoffman NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia Toward a paradigm shift in medication development Psychopharmacology 169 2003 215 233
31. J.H. Krystal, L.P. Karper, J.P. Seibyl, G.K. Freeman, R. Delaney, J.D. Bremner Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses Arch Gen Psychiatry 51 1994 199 214
32. A.C. Lahti, H.H. Holcomb, M.A. Weiler, D.R. Medoff, C.A. Tamminga Functional effects of antipsychotic drugs Comparing clozapine with haloperidol Biol Psychiatry 53 2003 601 608
33. A.J. Law, J.F. Deakin Asymmetrical reduction of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses Neuroreport 12 2001 2971 2974
34. J.C. Leveque, W. Macias, A. Rajadhyaksha, R.R. Carlson, A. Barczak, S. Kang Intracellular modulation of NMDA receptor function by antipsychotic drugs J Neurosci 20 2000 4011 4020
35. J.B. Levine, G. Martin, A. Wilson, S.N. Treistman Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner Neurosci Lett 346 2003 125 128
36. T.I. Lidsky, E. Yablonsky-Alter, L.G. Zuck, S.P. Banerjee Antipsychotic drug effects on glutamatergic activity Brain Res 764 1997 46 52
37. 11C]raclopride binding in the brain Model simulations and kinetic analysis of PET data J Cereb Blood Flow Metab 14 1994 995 1010
38. E.D. Luby, B.D. Cohen, G. Rosenbaum, J.S. Gottlieb, R. Kelley Study of a new schizophrenomimetic drug-sernyl Arch Neurol Psychiatry 81 1959 363 369
39. L. McCoy, E.K. Richfield Chronic antipsychotic treatment alters glycine-stimulated NMDA receptor binding in rat brain Neurosci Lett 213 1996 137 141
40. C.K. Meshul, G.L. Bunker, J.N. Mason, C. Allen, A. Janowsky Effects of subchronic clozapine and haloperidol on striatal glutamatergic synapses J Neurochem 67 1996 1965 1973
41. I. Ninan, K.E. Jardemark, R.Y. Wang Olanzapine and clozapine but not haloperidol reverse subchronic phencyclidine-induced functional hyperactivity of N-methyl-D-aspartate receptors in pyramidal cells of the rat medial prefrontal cortex Neuropharmacology 44 2003 462 472
42. Y. Nong, Y.Q. Huang, M.W. Salter NMDA receptors are movin' in Curr Opin Neurobiol 14 2004 353 361
43. S. Nudmamud, G.P. Reynolds Increased density of glutamate/N-methyl-D- aspartate receptors in superior temporal cortex in schizophrenia Neurosci Lett 18 2001 9 12
44. J.W. Olney, N.B. Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998 1007
45. K. Ossowska, M. Pietraszek, J. Wardas, G. Nowak, S. Wolfarth Chronic haloperidol and clozapine administration increases the number of cortical NMDA receptors in rats Naunyn Schmiedebergs Arch Pharmacol 359 1999 280 287
46. J. Overall, D. Gorham The brief psychiatric rating scale Psychol Rep 10 1962 799 812
47. 125I]-CNS 1261) A potential SPECT agent for imaging NMDA receptor activation Nucl Med Biol 27 2000 557 564
48. S.G. Potkin, M.S. Buchsbaum, Y. Jin, C. Tang, J. Telford, G. Friedman Clozapine effects on glucose metabolic rate in striatum and frontal cortex J Clin Psychiatry 55 1994 63 66
49. S.G. Potkin, Y. Jin, B.G. Bunney, J. Costa, B. Gulasekaram Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia Am J Psychiatry 156 1999 145 147
50. J.J. Rodriguez, V.M. Pickel Enhancement of N-methyl-D-aspartate (NMDA) immunoreactivity in residual dendritic spines in the caudate-putamen nucleus after chronic haloperidol administration Synapse 33 1999 289 303
51. S.S. Shim, E.R. Grant, S. Singh, M.J. Gallagher, D.R. Lynch Actions of butyrophenones and other antipsychotic agents at NMDA receptors Relationship with clinical effects and structural considerations Neurochem Int 34 1999 167 175
52. G.M. Simpson, J.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr Scand 212 1970 11 19
53. 123I]CNS-1261 in vivo Schizophr Bull 31 2005 466
54. 99mTc-ECD SPET Eur J Nucl Med Mol Imaging 29 2002 331 341
55. F.I. Tarazi, R.J. Baldessarini, N.S. Kula, K. Zhang Long-term effects of olanzapine, risperidone, and quetiapine on ionotropic glutamate receptor types Implications for antipsychotic drug treatment J Pharmacol Exp Ther 306 2003 1145 1151
56. F.I. Tarazi, W.J. Florijn, I. Creese Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics Psychopharmacology 128 1996 371 379
57. J. Ulas, L. Nguyen, C.W. Cotman Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex Neuroreport 4 1993 1049 1051
58. E.D. Zarnowska, J.W. Mozrzymas Differential effects of chlorpromazine on ionotropic glutamate receptors in cultured rat hippocampal neurons Neurosci Lett 305 2001 53 56